Pharmacoepidemiology and Drug Safety

Article	Citations
Time‐related biases in pharmacoepidemiology	74
Base de Datos para la Investigación Farmacoepidemiológica en Atención Primaria (BIFAP): A data resource for pharmacoepidemiology in Spain	44
Accuracy of Japanese claims data in identifying diabetes‐related complications	42
Control yourself: ISPE‐endorsed guidance in the application of self‐controlled study designs in pharmacoepidemiology	34
Core concepts in pharmacoepidemiology: Confounding by indication and the role of active comparators	33
Considerations for pharmacoepidemiological analyses in the SARS‐CoV‐2 pandemic	33
CPRD Aurum database: Assessment of data quality and completeness of three important comorbidities	31
QTc prolongation in COVID‐19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta‐analysis	28
Methods for external control groups for single arm trials or long‐term uncontrolled extensions to randomized clinical trials	27
Validation of diagnosis codes to identify hospitalized COVID‐19 patients in health care claims data	26
Analysis of immune‐related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database	25
Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death	24
Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006‐2016: A study in the five Nordic countries, United States, and Australia	23
Core concepts in pharmacoepidemiology: Violations of the positivity assumption in the causal analysis of observational data: Consequences and statistical approaches	22
Identifying drugs with disease‐modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology	21
Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning	21
Considerations when evaluating real‐world data quality in the context of fitness for purpose	21
Suicide‐related over‐the‐counter analgesic exposures reported to United States poison control centers, 2000‐2018	21
A COVID‐19‐ready public health surveillance system: The Food and Drug Administration's Sentinel System	21
Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data	20
Randomized, observational, interventional, and real‐world—What's in a name?	20
Assessing the impact of unmeasured confounders for credible and reliable real‐world evidence	20
Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID‐19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 3	20
Polypharmacy and the risk of drug–drug interactions and potentially inappropriate medications in hospital psychiatry	19
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real‐world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force	19

Sodium‐glucose cotransporter‐2 inhibitors and the risk of gout: A Danish population based cohort study and symmetry analysis	19
Antidepressant use in Australia and Sweden—A cross‐country comparison	19
Safety of Andrographis paniculata: A systematic review and meta‐analysis	19
Interventions to improve adverse drug reaction reporting: A scoping review	19
Validity of claims‐based algorithms for selected cancers in Japan: Results from the VALIDATE‐J study	18
Bipolar disorder prevalence and psychotropic medication utilisation in Hong Kong and the United Kingdom	17
A national study on prescribed medicine use in Australia on a typical day	17
Real‐world evidence to support regulatory decision making: New or expanded medical product indications	17
Translational hurdles with cannabis medicines	16
Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study	16
Improving transparency to build trust in real‐world secondary data studies for hypothesis testing—Why, what, and how: recommendations and a road map from the real‐world evidence	16
Factors associated with achieving target serum uric acid level and occurrence of gouty arthritis: A retrospective observational study of Japanese health insurance claims data	16
Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population‐based cohort studies	16
Utilization of drugs with reports on potential efficacy or harm on COVID‐19 before, during, and after the first pandemic wave	15
Validation of diagnostic coding for interstitial lung diseases in an electronic health record system in Hong Kong	15
Risk of incident dementia following metformin initiation compared with noninitiation or delay of antidiabetic medication therapy	15
Incidence rates of and risk factors for opioid overdose in new users of prescription opioids among US Medicaid enrollees: A cohort study	14
Real‐world data: Assessing electronic health records and medical claims data to support regulatory decision‐making for drug and biological products	14
Evaluation of more than one billion outpatient prescriptions and eight‐year trend showing a remarkable reduction in antibiotic prescription in Turkey: A success model of governmental interv	14
Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom	14
Incorporating patient generated health data into pharmacoepidemiological research	13
Validation of algorithms to estimate gestational age at birth in the Medicaid Analytic eXtract—Quantifying the misclassification of maternal drug exposure during pregnancy	13
Risk of pregnancy loss in patients exposed to mycophenolate compared to azathioprine: A retrospective cohort study	13
Using negative control outcomes to assess the comparability of treatment groups among women with osteoporosis in the United States	13
The Chang Gung Research Database: Multi‐institutional real‐world data source for traditional Chinese medicine in Taiwan	13
Validation of an ICD‐10‐based algorithm to identify stillbirth in the Sentinel System	12
Chronic opioid use and complication risks in women with endometriosis: A cohort study in US administrative claims	12
Validity of claims‐based algorithms to identify neurodevelopmental disorders in children	12
Safety of clozapine use during pregnancy: Analysis of international pharmacovigilance data	12
Assessing the incidence of osteosarcoma among teriparatide users based on Medicare Part D and US State Cancer Registry Data	12
Challenges facing drug utilization research in the Latin American region	12
Optimizing identification of resistant hypertension: Computable phenotype development and validation	12
Effect of ICD‐9‐CM to ICD‐10‐CM coding system transition on identification of common conditions: An interrupted time series analysis	12
Use of hydrochlorothiazide and risk of skin cancer in a large nested case‐control study in Spain	12
The association between aspirin use and depression: a systematic review and meta‐analysis of observational studies	12
Initial opioid prescription patterns and the risk of ongoing use and adverse outcomes	12
Risk of myopericarditis following COVID‐19 mRNA vaccination in a large integrated health system: A comparison of completeness and timeliness of two methods	12
Validity of congenital malformation diagnoses in healthcare claims from a university hospital in Japan	12
Using artificial intelligence to identify anti‐hypertensives as possible disease modifying agents in Parkinson's disease	11
Core concepts in pharmacoepidemiology: Validation of health outcomes of interest within real‐world healthcare databases	11
Trends in fall‐related mortality and fall risk increasing drugs among older individuals in the United States,1999–2017	11
Trends in strong opioid prescribing in Ireland: A repeated cross‐sectional analysis of a national pharmacy claims database between 2010 and 2019	11
Identification of pregnancies and infants within a US commercial healthcare administrative claims database	11
Core concepts in pharmacoepidemiology: Measures of drug utilization based on individual‐level drug dispensing data	11
Global COVID‐19 pandemic and reporting behavior ‐ An analysis of the Food and Drug Administration adverse events reporting system	11
Chronic pain patients' willingness to share personal identifiers on the web for the linkage of medico‐administrative claims and patient‐reported data: The chronic pain treatment cohort	11
Outcome misclassification: Impact, usual practice in pharmacoepidemiology database studies and an online aid to correct biased estimates of risk ratio or cumulative incidence	11
Medication‐related problems in older people in Catalonia: A real‐world data study	11
Identifying prescribing cascades in Alzheimer's disease and related dementias: The calcium channel blocker‐diuretic prescribing cascade	11
Validity of ICD‐10‐CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapies	11

Preparing for COVID‐19 vaccine safety surveillance: A United States perspective	11
Generalizability and accuracy of IBM MarketScan health risk assessment instrument data for augmentation of commercial claims data	11
Drug utilization study on immediate release Fentanyl in Spain. Prevalence, incidence, and indication	10
Use of negative controls in a prescription sequence symmetry analysis to reduce time‐varying bias	10
Building an active medical product safety surveillance system in Taiwan: Adaptation of the U.S. Sentinel System common data model structure to the National Health Insurance Research Database in Taiwan	10
Validation of an International Classification of Disease, 10th revision coding adaptation for the Charlson Comorbidity Index in United States healthcare claims data	10
Drug exposure misclassification in pharmacoepidemiology: Sources and relative impact	10
High‐dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting	10
Effectiveness of risk minimisation measures for valproate: A drug utilisation study in Europe	10
Developing algorithms for identifying major structural birth defects using automated electronic health data	10
Nintedanib and ischemic colitis: Signal assessment with the integrated use of two types of real‐world evidence, spontaneous reports of suspected adverse drug reactions, and observational data from lar	9
Potentially inappropriate medications among elderly patients in community healthcare institutions in Beijing, China	9
Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness?	9
Using administrative healthcare database records to study trends in prescribed medication dispensed during pregnancy in Belgium from 2003 to 2017	9
A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States ‐ 2007 to 2016	9
What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?	9
A systematic review of how missing data are handled and reported in multi‐database pharmacoepidemiologic studies	9
Reporting and variability of constructing medication treatment episodes in pharmacoepidemiology studies: A methodologic systematic review using the case study of DPP‐4 inhibitors and cardio	9
Bias in case‐crossover studies of medications due to persistent use: A simulation study	9
Use of record linkage to evaluate treatment outcomes and trial eligibility in a real‐world metastatic prostate cancer population in Scotland	9
Postoperative inpatient utilization of opioid and opioid‐sparing analgesics in the United States hospitals, 2007–2017	9
Multimorbidity measures from health administrative data using ICD system codes: A systematic review	9
Hydrochlorothiazide and risk of melanoma subtypes	8
Using machine learning to identify diabetes patients with canagliflozin prescriptions at high‐risk of lower extremity amputation using real‐world data	8
Drug interactions in hospital prescriptions in Denmark: Prevalence and associations with adverse outcomes	8
ICPE All Access conference abstracts	8
Impact of adherence to drugs for secondary prevention on mortality and cardiovascular morbidity: A population‐based cohort study. IMPACT study	8
Factors associated with the use of the prescription monitoring program by prescribers and pharmacists in Texas	8
Safety concerns reported by consumers, manufacturers and healthcare professionals: A detailed evaluation of opioid‐related adverse drug reactions in the FDA database over 15 years	8
Performance assessment of different machine learning approaches in predicting diabetic ketoacidosis in adults with type 1 diabetes using electronic health records data	8
Identification of rheumatoid arthritis in German claims data using different algorithms: Validation by cross‐sectional patient‐reported survey data	8
Nonsteroidal anti‐inflammatory drugs associated acute kidney injury in hospitalized children: A systematic review and meta‐analysis	8
Overview of the European post‐authorisation study register post‐authorization studies performed in Europe from September 2010 to December 2018	8
Evaluation of the key prescription sequence symmetry analysis assumption using the calcium channel blocker: Loop diuretic prescribing cascade	8
Medication persistence of targeted immunomodulators for plaque psoriasis: A retrospective analysis using a U.S. claims database	8
Categorization of COVID‐19 severity to determine mortality risk	8
Greedy caliper propensity score matching can yield variable estimates of the treatment‐outcome association—A simulation study	8
Impact of variable look‐back periods on the incidence rates of chronic diseases using real world data	8
Core concepts in pharmacoepidemiology: Key biases arising in pharmacoepidemiologic studies	7
Real‐world data in Saudi Arabia: Current situation and challenges for regulatory decision‐making	7
Trends in benzodiazepine and alternative hypnotic use in relation with multimorbidity among older adults in Quebec, Canada	7
Risk of common infections among individuals with psoriasis in Sweden: A nationwide cohort study comparing secukinumab to ustekinumab	7
Validity of a model using routinely collected data for identifying infections following gastric, colon, and liver cancer surgeries	7
	7
Association between antidepressant use in pregnancy and gestational diabetes mellitus: Results from the Norwegian Mother, Father and Child Cohort Study	7
Attention‐deficit/hyperactivity disorder medication and risk of suicide attempt: A meta‐analysis of observational studies	7
COVID‐19 pharmacotherapy utilization patterns during pregnancy: International Registry of Coronavirus Exposure in Pregnancy	7
Transparency of high‐dimensional propensity score analyses: Guidance for diagnostics and reporting	7
The utility of real‐world evidence for benefit‐risk assessment, communication, and evaluation of pharmaceuticals: Case studies	7
New‐user and prevalent‐user designs and the definition of study time origin in pharmacoepidemiology: A review of reporting practices	7
Using the waiting time distribution with random index dates to estimate prescription durations in the presence of seasonal stockpiling	7
Chronic prescription opioid use in pregnancy in the United States	7
Health outcomes coding trends in the US Food and Drug Administration's Sentinel System during transition to International Classification of Diseases‐10 coding system: A brief review	7
	7
Sulphonylureas monotherapy and risk of hospitalization for heart failure in patients with type 2 diabetes mellitus: A population‐based cohort study in China	7
Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetes	7
Differential frequency in imaging‐based outcome measurement: Bias in real‐world oncology comparative‐effectiveness studies	7
Use of a mobile app to capture supplemental health information during pregnancy: Implications for clinical research	7
Estimation of adverse drug reaction reporting in Iran: Correction for underreporting	7
Validity of identification algorithms combining diagnostic codes with other measures for acute ischemic stroke in MID‐NET®	7
Use of negative control outcomes to assess the comparability of patients initiating lipid‐lowering therapies	6
Time‐related biases in perinatal pharmacoepidemiology: A systematic review of observational studies	6
Ondansetron use in early pregnancy and the risk of late pregnancy outcomes	6
Where to begin? Thirty must‐read papers for newcomers to pharmacoepidemiology	6
Effect of concomitant antiplatelet therapy on ischemic and hemorrhagic events in patients taking oral anticoagulants for nonvalvular atrial fibrillation in daily clinical practice	6
Impact of direct‐acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers	6
Emergency hospitalizations for adverse drug events in China: Clinical pharmacists' approach to assessment and categorization	6
High concordance between chart review adjudication and electronic medical record data to identify prevalent and incident diabetes mellitus among persons with and without HIV	6
Use of hydrochlorothiazide in Denmark following publication of skin cancer risk findings	6
Rapid monitoring of health services utilization following a shift in coverage from brand name to biosimilar drugs in British Columbia—An interim report	6
Alzheimer's disease and related dementias risk: Comparing users of non‐selective and M3‐selective bladder antimuscarinic drugs	6
Tenofovir disoproxil fumarate associated nephrotoxicity: a retrospective cohort study at two referral hospitals in Namibia	6
More extreme duplication in the U.S. FDA FAERS database and a suggested check point for disproportionality analysis	6
Phosphodiesterase type 5 inhibitor use among pregnant and reproductive‐age women in the United States	6
Inflammatory bowel disease patients provide reliable self‐reported medical information: A multicentre prospective pharmacovigilance monitoring system	6
A systematic review and meta‐analysis of observational studies of the association between the use of incretin‐based therapies and the risk of pancreatic cancer	6
Acute kidney injury identification for pharmacoepidemiologic studies: Use of laboratory electronic acute kidney injury alerts versus electronic health records in Hospital Episode Statistics	6
Identifying frequent drug combinations associated with delirium in older adults: Application of association rules method to a case‐time‐control design	6
Pharmacovigilance network as an additional tool for the surveillance of antimicrobial resistance	6
Methods for drug safety signal detection using routinely collected observational electronic health care data: A systematic review	6

Trends in the use of disease‐modifying therapies among reproductive‐aged women with multiple sclerosis in the United States from 2010 to 2019	6
Prediction of post‐vaccination Guillain‐Barré syndrome using data from a passive surveillance system	6
An investigation on the association between sodium glucose co‐transporter 2 inhibitors use and acute pancreatitis: A VigiBase study	6
Drug product dispensing and estimates of use in a general population survey as a signal detection problem	6
Relation between anticholinergic burden and cognitive impairment: Results from the Monzino 80‐plus population‐based study	6
SGLT‐2 inhibitors and the risk of hospitalization for community‐acquired pneumonia: A population‐based cohort study	6
Treatment resistant depression incidence and prevalence using the French nationwide claims database	6
Pharmacological and epidemiological considerations while constructing treatment episodes using observational data: A simulation study	6
Pharmacoepidemiology of testosterone: Impact of reimbursement policy on curbing off‐label prescribing	6
Validation of diagnosis codes in healthcare databases in Taiwan, a literature review	6
Thromboembolic events after Ad.26.COV2.S COVID‐19 vaccine: Reports to the Vaccine Adverse Event Reporting System	6
Very high PD‐L1 expression as a prognostic indicator of overall survival among patients with advanced non‐small cell lung cancer receiving anti‐PD‐(L)1 monotherapies i	6
Data sources for drug utilization research in Latin American countries—A cross‐national study: DASDUR‐LATAM study	6
Development and validation of coding algorithms to identify patients with incident lung cancer in United States healthcare claims data	6
Off‐label drug use in neonates and infants in Spain: A five‐year observational study	5
Association between domperidone use and adverse cardiovascular events: A nested case‐control and case‐time‐control study	5
In utero exposure to analgesic opioids and language development in 5‐year old children	5
Ethnic inequality in non‐steroidal anti‐inflammatory drug‐associated harm in New Zealand: A national population‐based cohort study	5
Exposure to nitrosatable drugs during pregnancy and childhood cancer: A matched case–control study in Denmark, 1996–2016	5
Validation studies of Japanese administrative health care data: A scoping review	5
Impact of a nationwide prospective drug utilization review program to improve prescribing safety of potentially inappropriate medications in older adults: An interrupted time series with segmented reg	5
Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy	5
Proton pump inhibitors may enhance the risk of citalopram‐ and escitalopram‐associated sudden cardiac death among patients receiving hemodialysis	5
Risk of major congenital malformations associated with first‐trimester exposure to propulsives: A health administrative database study in Japan	5
Assessing polypharmacy in the older population: Comparison of a self‐reported and prescription based method	5
Implementing high‐dimensional propensity score principles to improve confounder adjustment in UK electronic health records	5
Prescribing of menopausal hormone therapy in Germany: Current status and changes between 2004 and 2016	5
Risk of delirium associated with antimuscarinics in older adults: A case‐time‐control study	5
Feasibility of using Clinical Practice Research Datalink data to identify patients with chronic obstructive pulmonary disease to enrol into real‐world trials	5
Validation of venous thromboembolism diagnoses in patients receiving rivaroxaban or warfarin in The Health Improvement Network	5
Signals from the Dutch national spontaneous reporting system: Characteristics and regulatory actions	5
Prevalence and incidence rate of hospital admissions related to medication between 2008 and 2013 in The Netherlands	5
	5
Method used to identify adenomyosis and potentially undiagnosed adenomyosis in a large, U.S. electronic health record database	5
Mobile apps for quick adverse drug reaction report: A scoping review	5
SARS‐CoV‐2 vaccine‐related adverse events in Zimbabwe: The need to strengthen pharmacovigilance in resource‐limited settings	5
No association between use of phosphodiesterase 5 inhibitors and colorectal cancer in men with erectile dysfunction	5
Drug discontinuation in pregnant women with psoriasis: The PSO‐MOTHER cohort study	5
Nonsteroidal anti‐inflammatory drugs use in patients with chronic kidney disease are often prescribed from different clinicians than those who diagnosed them	5
Association of baloxavir marboxil prescription with subsequent medical resource utilization among school‐aged children with influenza	5
Real‐world effectiveness of pembrolizumab in previously treated non‐small cell lung cancer: A population‐based cohort study	5
	5
Prevalence and distribution of high‐risk prescription opioid use in the United States, 2011–2016	5
Suitability of databases in the Asia‐Pacific for collaborative monitoring of vaccine safety	5
Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data	5
The role of prenatal exposure to antidepressants, anxiolytic, and hypnotics and its underlying illness on the risk of miscarriage using BIFAP database	5
Real‐world reproducibility study characterizing patients newly diagnosed with multiple myeloma using Clinical Practice Research Datalink, a UK‐based electronic health records database	5
Memantine misuse and social networks: A content analysis of Internet self‐reports	5
Bias of time‐varying exposure effects due to time‐varying covariate measurement strategies	5
Comparison of the incidence of bleeding between baloxavir marboxil and other anti‐influenza drugs among outpatients with influenza virus infection: A retrospective cohort study using an employment‐bas	5
Analysis of the US FDA adverse event reporting system to identify adverse cardiac events associated with hydroxychloroquine in older adults	5
Validation of an electronic algorithm for Hodgkin and non‐Hodgkin lymphoma in ICD‐10‐CM	5
Quantifying cumulative anticholinergic and sedative drug load among US Medicare Beneficiaries	5
Use of preventive drugs during the last year of life in older adults with cancer or chronic progressive diseases	5
Identifying opioid dose reductions and discontinuation among patients with chronic opioid therapy	5
Development and validation of an electronic health records‐based opioid use disorder algorithm by expert clinical adjudication among patients with prescribed opioids	5
Spillover effects of state medicaid antipsychotic prior authorization policies in US commercially insured youth	4
A comparison of confounder selection and adjustment methods for estimating causal effects using large healthcare databases	4
Validating a novel algorithm to identify patients with autoimmune hepatitis in an administrative database	4
Comparison of laboratory threshold criteria in drug‐induced liver injury detection algorithms for use in pharmacovigilance	4
Baseline anticholinergic burden from medications predicts poorer baseline and long‐term health‐related quality of life in 16 675 men and women of EPIC‐Norfolk prospective population‐based c	4
Use of intravenous iron and risk of anaphylaxis: A multinational observational post‐authorisation safety study in Europe	4
Real world data to identify target population for new CAR‐T therapies	4
Association between pre‐admission anticoagulation and in‐hospital death, venous thromboembolism, and major bleeding among hospitalized COVID‐19 patients in Japan	4
Effectiveness and use of reverse transcriptase polymerase chain reaction point of care testing in a large‐scale COVID‐19 surveillance system	4
Hepatic adverse drug reactions in Malaysia: An 18‐year review of the national centralized reporting system	4
Evaluation of the efficacy and safety of romosozumab (evenity) for the treatment of osteoporotic vertebral compression fracture in postmenopausal women: A systematic review and meta‐analysis of random	4
Effectiveness of risk minimisation measures for valproate: A cross‐sectional survey among physicians in Europe	4
Antibiotic utilization within 18 community hospitals in the United States: A 5‐year analysis	4
Meta‐analysis of the risk of autoimmune thyroiditis, Guillain‐Barré syndrome, and inflammatory bowel disease following vaccination with AS04‐adjuvanted human papillomavirus 16/18	4
Comparative risk of Parkinsonism associated with olanzapine, risperidone and quetiapine in older adults‐a propensity score matched cohort study	4
Ways COVID‐19 may impact unrelated pharmacoepidemiologic research using routinely collected data	4
Predicting obesity and smoking using medication data: A machine‐learning approach	4
Perinatal pharmacoepidemiology: How often are key methodological elements reported in publications?	4
International trends in prescription opioid sales among developed and developing economies, and the impact of the COVID‐19 pandemic: A cross‐sectional analysis of 66 countries	4
Increasing rates of buprenorphine diversion in the United States, 2002 to 2019	4
Glucosamine and lower mortality and cancer incidence: Selection bias in the observational studies	4
Does additional monitoring status increase the reporting of adverse drug reactions? An interrupted time series analysis of EudraVigilance data	4
Outcomes in patients with lung cancer treated with crizotinib and erlotinib in routine clinical practice: A post‐authorization safety cohort study conducted in Europe and in the United States	4
Comparing LASSO and random forest models for predicting neurological dysfunction among fluoroquinolone users	4
The controversy around technical standards for similar biotherapeutics: barriers to access and competition?†	4
Off‐label low dose amitriptyline for insomnia disorder: Patient‐reported outcomes	4
Tell me what you want, what you really really want: Estimands in observational pharmacoepidemiologic comparative effectiveness and safety studies	4
Utilization of nonguideline concordant antibiotic treatment following acute otitis media in children in the United States	4
Machine learning for improving high‐dimensional proxy confounder adjustment in healthcare database studies: An overview of the current literature	4
Validity of administrative claims‐based algorithms for ventricular arrhythmia and cardiac arrest in the pediatric population	4
Linkage of public health and all payer claims data for population‐level opioid research	4
General practitioner prescribing trends among pediatric patients in the United Kingdom: 1998–2018	4
Medications used disproportionately during pregnancy: Priorities for research on the risks and benefits of medications when used during pregnancy	4
Real‐world on‐treatment and initial treatment absolute risk differences for dabigatran vs warfarin in older US adults	4
Validation of algorithms to select patients with multiple myeloma and patients initiating myeloma treatment in the national Veterans Affairs Healthcare System	4
Allopurinol‐induced severe cutaneous adverse drug reactions: Risk minimization measures in Malaysia	4
Ondansetron use in early pregnancy and the risk of miscarriage	4
Cardiovascular events and all‐cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long‐acting beta2‐agonists	4
Core concepts in pharmacoepidemiology: Fundamentals of the cohort and case–control study designs	4